BioBiz Buzz
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries.
Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences.
Disclaimer
https://biobizbuzz.com/disclaimer/
Podcasting since 2025 • 23 episodes
BioBiz Buzz
Latest Episodes
23. Thalia’s Big Bet on Gene Silencing: Once‑Yearly RNA to Tackle Hidden Cardiac Risk
What if an annual self-injection could silence your hidden cardiac risk instead of just lowering your LDL?In this episode of BioBiz Buzz, Mike Ward sits down with David Solomon, CEO of Thalia Therapeutics, to unpack how a once-yearly RNA...
•
Season 2
•
Episode 4
•
23:53
22. Unlocking the Undruggable: Quantro Therapeutics’ Mission to Transform Cancer Treatment
For more than three decades, transcription factors have been the great white whale of oncology drug discovery; tantalising, genetically validated, mechanistically central, and yet stubbornly out of reach. They sit at the heart of cancer biology...
•
Season 2
•
Episode 3
•
38:01
21. Targeting What Others Miss: How HaemaLogiX Is Tackling Multiple Myeloma's Toughest Challenges
Multiple myeloma remains the second-largest blood cancer globally with no cure, and despite recent breakthroughs in CAR-T and antibody therapies, patients continue to relapse, often losing the very antigens that therapies target. In this episod...
•
Season 2
•
Episode 2
•
29:57
20. Redefining HIV Treatment and Prevention: Gilead’s Next Chapter
In this episode of BioBiz Buzz, your host Mike Ward sits down with Dr. Jared Baeten, Senior Vice President for Clinical Development and Head of the Virology Therapeutic Area at Gilead Sciences, to explore how new data from CROI 2026 could signa...
•
Season 2
•
Episode 1
•
34:00
19. From Genesis to Revelations: Winners & Losers in Pharma’s Most Volatile Year
2025 has been a seismic year for the pharmaceutical industry, a year of extremes where innovation superpowers emerge alongside spectacular collapses. In this special episode, BioBiz Buzz host Jo Shorthouse sits down with Mike Ward, Global Head ...
•
Season 1
•
Episode 19
•
25:09
